These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9825111

  • 1. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract] [Full Text] [Related]

  • 2. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T, Fujimura A, Harada K, Sunaga K, Ohmori M, Sakamoto K.
    Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, Fabian W, Kinzig M, Naber KG, Sörgel F.
    Clin Pharmacokinet; 1992; 22 Suppl 1():24-32. PubMed ID: 1319868
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different effects of products containing metal ions on the absorption of lomefloxacin.
    Lehto P, Kivistö KT.
    Clin Pharmacol Ther; 1994 Nov; 56(5):477-82. PubMed ID: 7955811
    [Abstract] [Full Text] [Related]

  • 16. Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
    Lefebvre HP, Schneider M, Dupouy V, Laroute V, Costes G, Delesalle L, Toutain PL.
    J Vet Pharmacol Ther; 1998 Dec; 21(6):453-61. PubMed ID: 9885968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Marbofloxacin in equine medicine: have we got the doses right?
    Lees P, Aliabadi FS.
    Equine Vet J; 2002 Jul; 34(4):322-5. PubMed ID: 12117100
    [No Abstract] [Full Text] [Related]

  • 19. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE, Vorob'ev PA, Dvoretskiĭ LI, Izotova GN, Miagkov AV, Shvyreva GS, Iakovlev SV.
    Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
    [Abstract] [Full Text] [Related]

  • 20. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
    Post LO, Farrell DE, Cope CV, Baker JD, Myers MJ.
    J Pharmacol Exp Ther; 2003 Feb; 304(2):889-95. PubMed ID: 12538847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.